Oxidation of reduced nicotinamide-adenine dinucleotide by the malate-aspartate shuttle in Ehrlich ascites tumour cells.
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors; D001224:Aspartic Acid / Q000378:metabolism*; D001562:Benzimidazoles / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology / Q000378:metabolism*; D004579:Electron Transport; D004735:Energy Transfer; D006898:Hydroxylamines / Q000494:pharmacology; D007700:Kinetics; D007773:Lactates; D008293:Malates / Q000378:metabolism*; D051379:Mice; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009243:NAD / Q000378:metabolism*; D009584:Nitrogen / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010084:Oxidation-Reduction; D012402:Rotenone / Q000494:pharmacology; D013997:Time Factors
D000085:Acetates; D001562:Benzimidazoles; D006898:Hydroxylamines; D007773:Lactates; D008293:Malates; D009840:Oligomycins; D012402:Rotenone; D009243:NAD; D001224:Aspartic Acid; D000968:Antimycin A; D001219:Aspartate Aminotransferases; D009584:Nitrogen